UCB S.A. Stock
Price
Target price
€235.80
€235.80
-2.240%
-5.4
-2.240%
-
12.12.25 / Tradegate
WKN: 852738 / Symbol: UCBJF / Name: UCB SA / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
UCB S.A. Stock
A loss of -2.240% shows a downward development for UCB S.A..
So far the community has only identified positive things for UCB S.A. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of UCB S.A. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of UCB S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| UCB S.A. | -2.240% | -4.689% | 2.611% | 30.637% | 23.747% | 224.883% | 169.363% |
| Bayer AG ADR | 1.700% | 4.678% | 30.657% | 90.426% | 80.444% | -31.154% | -23.504% |
| Roche Holding AG ADR | -1.300% | 2.864% | 9.153% | 25.461% | 27.949% | 10.827% | 19.456% |
| Astrazeneca ADR | -0.650% | -0.645% | 1.316% | 20.313% | 20.313% | 17.021% | 71.875% |
Comments
UCB (OTCMKTS:UCBJF) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for UCBJF provided by MarketBeat
UCB (OTCMKTS:UCBJF) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Show more
Ratings data for UCBJF provided by MarketBeat
UCB SA (OTCMKTS: UCBJF) was upgraded by analysts at Morgan Stanley to an "overweight" rating.
Show more
Ratings data for UCBJF provided by MarketBeat